Clinical Research and GCP Update

29 CRITICAL sponsor findings – Data Integrity Control

• There was a lack of contemporaneous documentation of the actions taken following accidental unblinding within the trial to demonstrate how any potential bias was minimised. • There was no process for ensuring that any inadvertent unblinding or unplanned unblinding was transparently documented in the Clinical Study Report (CSR).

29

30

© Brookwood Global (Canary Ltd) 2021

15